Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 Feb 17. doi: 10.1002/ajh.25438. [Epub ahead of print] No abstract available.

PMID:
30773707
2.

Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K, Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Jan 22. doi: 10.1038/s41409-019-0434-3. [Epub ahead of print]

PMID:
30670824
3.

Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation.

Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A.

Transpl Infect Dis. 2019 Jan 17:e13049. doi: 10.1111/tid.13049. [Epub ahead of print]

PMID:
30656802
4.

Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study.

Iwasaki M, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A.

BMC Infect Dis. 2019 Jan 9;19(1):38. doi: 10.1186/s12879-018-3665-9.

5.

Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin.

Kako S, Gomyo A, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda J, Kanda Y.

Eur J Haematol. 2019 Mar;102(3):256-264. doi: 10.1111/ejh.13204. Epub 2019 Jan 9.

PMID:
30578673
6.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J.

Haematologica. 2018 Dec 6. pii: haematol.2018.204438. doi: 10.3324/haematol.2018.204438. [Epub ahead of print]

7.

Endovascular Therapy Using Diluted Contrast Medium for Critical Limb Ischemia in a Patient with Chronic Kidney Disease.

Hayakawa N, Kodera S, Ohki N, Kushida S, Morita H, Kanda J, Komuro I.

Int Heart J. 2019 Jan 25;60(1):226-230. doi: 10.1536/ihj.18-125. Epub 2018 Nov 20.

8.

Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.

Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Leuk Lymphoma. 2018 Nov 20:1-10. doi: 10.1080/10428194.2018.1535115. [Epub ahead of print]

PMID:
30457400
9.

Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T, Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, Fukuda T, Kanda J, Atsuta Y, Suzuki R.

Int J Hematol. 2019 Feb;109(2):175-186. doi: 10.1007/s12185-018-2560-x. Epub 2018 Nov 14.

PMID:
30430419
10.

Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease.

Nishi K, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2178-2183. doi: 10.1016/j.bbmt.2018.06.031. Epub 2018 Jul 3.

PMID:
30417828
11.

Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.

Yokoyama H, Kanda J, Kato S, Kondo E, Maeda Y, Saji H, Takahashi S, Onizuka M, Onishi Y, Ozawa Y, Kanamori H, Ishikawa J, Ohno Y, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2018 Nov 6. doi: 10.1038/s41409-018-0369-0. [Epub ahead of print]

PMID:
30401965
12.

Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.

Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M, Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, Kanda J, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 Jan;94(1):103-110. doi: 10.1002/ajh.25336. Epub 2018 Nov 29.

PMID:
30370944
13.

Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation.

Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A.

Biol Blood Marrow Transplant. 2018 Oct 22. pii: S1083-8791(18)30647-5. doi: 10.1016/j.bbmt.2018.10.014. [Epub ahead of print]

PMID:
30359733
14.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Blood Adv. 2018 Oct 23;2(20):2744-2754. doi: 10.1182/bloodadvances.2018020305.

15.

Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia.

Atsuta Y, Kato S, Morishima Y, Ohashi K, Fukuda T, Ozawa Y, Eto T, Iwato K, Uchida N, Ota S, Onizuka M, Ichinohe T, Kanda J, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2018 Oct 8. pii: S1083-8791(18)30611-6. doi: 10.1016/j.bbmt.2018.10.002. [Epub ahead of print]

PMID:
30308326
16.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini P, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, Holtan SG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2019 Feb;25(2):270-278. doi: 10.1016/j.bbmt.2018.09.004. Epub 2018 Oct 3.

PMID:
30292009
17.

Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.

Iemura T, Itoh M, Mano C, Oba A, Kawabata N, Horisawa Y, Matsui M, Miyahara Y, Kanda J.

Transfusion. 2018 Dec;58(12):2773-2776. doi: 10.1111/trf.14885. Epub 2018 Sep 28.

PMID:
30265752
18.

Evaluation of a Novel Classification of Heat-Related Illnesses: A Multicentre Observational Study (Heat Stroke STUDY 2012).

Yamamoto T, Fujita M, Oda Y, Todani M, Hifumi T, Kondo Y, Shimazaki J, Shiraishi S, Hayashida K, Yokobori S, Takauji S, Wakasugi M, Nakamura S, Kanda J, Yagi M, Moriya T, Kawahara T, Tonouchi M, Yokota H, Miyake Y, Shimizu K, Tsuruta R.

Int J Environ Res Public Health. 2018 Sep 8;15(9). pii: E1962. doi: 10.3390/ijerph15091962.

19.

[Selection of Chemotherapy Regimen on the Basis of Monitoring NLR and Soluble PD-L1 during CRC Chemotherapy].

Muneoka K, Shirai Y, Sasaki M, Honma S, Sakata J, Kanda J, Wakabayashi H, Wakai T, Miyazaki M.

Gan To Kagaku Ryoho. 2018 Aug;45(8):1159-1163. Japanese.

PMID:
30158411
20.

An Autopsy Case of Familial Neuronal Intranuclear Inclusion Disease with Dementia and Neuropathy.

Yamaguchi N, Mano T, Ohtomo R, Ishiura H, Almansour MA, Mori H, Kanda J, Shirota Y, Taira K, Morikawa T, Ikemura M, Yanagi Y, Murayama S, Shimizu J, Sakurai Y, Tsuji S, Iwata A.

Intern Med. 2018 Dec 1;57(23):3459-3462. doi: 10.2169/internalmedicine.1141-18. Epub 2018 Aug 10.

Supplemental Content

Loading ...
Support Center